Stock Ratings / Health Care / ATRC / dividends

NVST (49) PLSE (41) IRTC (48) ICUI (55) ⌘ Pro Terminal →

AtriCure Inc. (ATRC) Dividend Safety Gauge & 10-Year DRIP Compounder

$62.48 +1.73% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $62.56

AtriCure Inc. (ATRC) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $3.18B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $62.55 (+0.12%)🧬 Disciplined Float (+1.08% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY • 54.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+2.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ATRC)Realized 20D OHLCV Swing Band: ±8.1%

Deterministic 5-Pillar Attribution (63/100 Composite)

🔍 WHY ATRC SCORES 63/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (25% of score)

Altman Z-Score 12.08 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Macro Regime Fit+15/20 pts (24% of score)

FRED Regime × Technicals: 99% of 52W Range • RSI-14 at 62.9 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution8/20 pts (-12 pt drag)

Disciplined Float (+1.08% YoY Shares) & executive Form 4 sales trim 12 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$55.81+0.5% Next Q

Q2 (-2Q)

Grade C$56.07+5.2% Next Q

Q3 (-1Q)

Grade C$58.97+6% Next Q

Current

Grade C$62.48+0.9% Hist 90D α

Trajectory: C (55) → C (63)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ATRC Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 63/100 (C) score, ATRC faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (+1.08% YoY Shares) — any gross margin slip below 72.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($55.58) or 200D SMA ($38.09) invalidates the momentum regime and cuts Target Base ($63.89) toward Bear Floor ($49.83).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ATRC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ATRC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 63%NO 37%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

0.6% Total Yield

0% Cash ($0.00/yr) + 0.6% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (8.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $23,243

Est. Year-10 Shareholder Yield: $139/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.9K

Yr 1

$11.8K

Yr 2

$12.9K

Yr 3

$14.0K

Yr 4

$15.2K

Yr 5

$16.6K

Yr 6

$18.0K

Yr 7

$19.6K

Yr 8

$21.4K

Yr 9

$23.2K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in ATRC & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on ATRC and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ATRC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +122.27%▲ ASCENDING CHANNEL

2026-10-30O $62.41H $62.48L $59.70C $62.48VOL 966.4K

RES: $71.12SUP: $57.48SMA50: $55.58SMA200: $38.09

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ATRC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ATRC Butterfly Map → + Track ATRC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +14.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ATRC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ATRC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ATRC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ATRC)

Health Care Rank #156 of 1016 ⚔️ NVST vs ATRC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ATRC vs. NVST, PLSE, IRTC, ICUI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, AtriCure Inc. (ATRC) ranks #156 by composite RQD confidence (63/100, grade C) and #203 by equity capitalization ($3.18B). Within this direct 5-issuer industry benchmark cohort, NVST leads on earnings valuation at 84.1x trailing P/E, while NVST leads on capital efficiency and profitability with 5.1% ROIC and 54.7% gross margin. ATRC currently leads its immediate peer cohort in composite quantitative strength at 63/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ATRC ACTIVE AtriCure Inc.	C	63/100	—	75.0%	-1.9%	+1.73%	$3.18B	Benchmark Subject
NVST Envista Holdings Corporation	D	49/100	84.1x	54.7%	5.1%	+2.80%	$3.95B	/nvst-vs-atrc →
PLSE Pulse Biosciences Inc	D-	41/100	—	-30.0%	-30.7%	+3.37%	$3.96B	/plse-vs-atrc →
IRTC iRhythm Holdings Inc.	D	48/100	—	70.6%	-13.5%	+3.07%	$4.21B	/irtc-vs-atrc →
ICUI ICU Medical Inc.	D+	55/100	—	36.8%	1.0%	+1.36%	$4.22B	/icui-vs-atrc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001323885

In its most recent audited fiscal period (FY2025, filed 2025-12-31), AtriCure Inc. (ATRC) reported GAAP revenue of $534.5M (+14.9% vs. FY2024 revenue of $465.3M , and +33.9% cumulative change since FY2023) , GAAP net income of -$11.4M, operating cash flow of $57.3M, and free cash flow of $48.3M (+6381.1% YoY). On the balance sheet, ATRC closed FY2025 with $654.2M in total assets against $61.9M in total debt (Altman Z-Score: 12.08, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$534.5M	-$11.4M	$57.3M	$48.3M	$654.2M	$61.9M
FY2024 (FY)	2024-12-31	$465.3M	-$44.7M	$12.2M	$745.0K	$609.3M	$61.9M
FY2023 (FY)	2023-12-31	$399.2M	-$30.4M	$4.5M	$4.5M	—	—

3. ATRC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ATRC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, AtriCure Inc. (NASDAQ: ATRC) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $62.48 (+1.73% 1D, market cap $3.18B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 8/20. Across 1016 tracked Health Care issuers, ATRC ranks #156 in composite RQD confidence.

How does ATRC compare to NVST and PLSE in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), ATRC carries a Roarable C (63/100 RQD), trailing P/E of N/A, gross margin of 75.0%, and ROIC of -1.9%. By comparison, NVST (Envista Holdings Corporation) holds a D grade (49/100 RQD, P/E 84.1x, ROIC 5.1%, cap $3.95B) and PLSE (Pulse Biosciences Inc) posts a D- grade (41/100 RQD, P/E N/A, ROIC -30.7%, cap $3.96B). Among the 5-stock peer group, NVST leads on earnings multiple (84.1x) while NVST leads on capital efficiency (5.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ATRC?

Per ATRC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001323885), AtriCure Inc. generated $534.5M in revenue (+14.9% YoY), -$11.4M in net income, and $48.3M in free cash flow against $654.2M in total assets and $61.9M in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ATRC trading relative to its 50-day, 200-day, and 52-week technical levels?

ATRC last traded at $62.48 (+1.73% on volume of 702,406 shares), positioning the stock +12.41% above its 50-day simple moving average ($55.58) and +64.03% above its 200-day simple moving average ($38.09). Across its 52-week range of $25.36 to $63.00, ATRC sits at the 98.6% percentile with a 14-day RSI of 62.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.1% ($57.42 to $67.54).

ATRC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does ATRC pay a dividend and is it safe?

AtriCure Inc. (ATRC) offers a 0% cash dividend yield ($0.00 annualized) and 0.6% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: ATRC RQD Cockpit ATRC 12M Forecast ATRC Earnings & Move ATRC Dividends & DRIP ATRC Insiders & 13F ATRC Whale Options ATRC Profit Sankey ATRC News & Why